FN1 and prostate carcinoma: Evidently, the metastasizing cells’ diverse extracellular environment and their own substrate-sensing proteome may be a major determinant of the biophysical phenotypes that arise throughout prostate cancer progression, which may be more diverse in vivo than those reported here for monolayers plated on fibronectin.